Overview
The goal of this study is to find a new way to make diabetes care better for patients with breast cancer and diabetes who are currently receiving cancer treatment. We will have two groups, the researchers will decide who is in which group. One group will be working with a nurse who is trained in diabetes care while the other does not. This will allow the investigators to see if having a trained nurse as part of the care team can help improve the care the patients receive.
Description
The present study aims to develop a stakeholder-engaged nurse practitioner (NP)-led intervention to improve diabetes care for patients with breast cancer and diabetes who are undergoing cancer treatment.
This is a pilot feasibility study, in which we will use a quasi-experimental pre-post design with non-randomized intervention and control groups. In this feasibility study, the investigators will first enroll 38 eligible patients for the control group and collect effectiveness measures at baseline and follow-up (end of chemotherapy or other cancer treatment, ~12 weeks). Through chart review, the investigators will document cancer treatment regimen completion at follow-up. The investigators will then enroll 38 patients for the intervention group, collecting the effectiveness and implementation outcomes at the end of their treatment (~12 weeks).
The main hypothesis that will be tested in this pilot study is that a nurse practitioner embedded in the oncology team who is trained in diabetes management may successfully manage diabetes during active cancer care for patients undergoing cancer treatment.
Eligibility
Inclusion Criteria:
- Newly diagnosed invasive cancer
- Plan to receive neo-adjuvant or adjuvant chemotherapy, targeted therapy, hormonal
therapy, or radiation at Weill Cornell Medicine (WCM)
- Age 18+ years
- Pre-diabetes OR type 2 diabetes. Treatment with antidiabetic medication OR
- HbA1c greater than or equal to 5.7 OR
- Random glucose greater than or equal to OR
- Fasting blood glucose greater than or equal to 100
Exclusion Criteria:
- Patients receiving hospice care
- Type 1 diabetes